100% Secure Payments
Tender Details
- Country: USA
- Summary: Assay Validation of High Quality Markers for Clinical Studies in Cancer (Uh3 Clinical Trials not Allowed)
- UST Ref No: 46537928
- Deadline: 10 Oct 2023
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: -
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: PAR-20-314
- Purchaser's Detail :
- Description :
- Tender are invited for Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
CFDA Number : 93.394 -- Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement : No
Closing Date for Applications: Oct 10, 2023
Posted Date : Oct 13, 2020
Description: The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the adoption and validation of molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This FOA will also support the validation of pharmacodynamic markers and markers of toxicity. Applicants to this FOA must have an assay(s) whose performance has been analytically validated in specimens similar to those for the intended clinical use of the marker(s) and assay(s). As chemotherapies and/or radiation therapies are increasingly combined with immunotherapies to enhance the durability of anti-cancer responses, assays for measuring multiple markers, including immune markers, can be developed and validated simultaneously. The UH3 mechanism will support the clinical validation of established assays for up to 3 years using specimens from retrospective or prospective clinical trials or studies. This FOA may be used to validate existing assays for use... - Documents :
Purchaser : NATIONAL INSTITUTES OF HEALTH
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Email :FBOWebmaster@OD.NIH.GOV
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
